article thumbnail

STAT+: GLP-1s lower risk of 10 obesity-associated cancers, study shows

STAT

New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives. million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin.

Diabetes 362
article thumbnail

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Express Pharma

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. Products in this category are often prescribed by practitioners, such as nephrologists for renal care or diabetologists for managing diabetes. People started understanding the importance of maintaining their health proactively.

Diabetes 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Balancing Blood Sugar is Vital for Hashimoto’s Health

The Thyroid Pharmacist

A review paper published in 2010 that discussed the relationship between thyroid dysfunction and metabolic disorders, highlighted the fact that patients with diabetes were up to three times more likely to develop a thyroid disorder. (7). Hypoglycemia is an early risk factor for developing diabetes. Type 2 Diabetes.

article thumbnail

Is Stevia Good or Bad for Hashimoto’s Disease?

The Thyroid Pharmacist

I knew he was right — sugar can contribute to a yeast overgrowth, lowered immunity, blood sugar issues, weight gain, diabetes, and a whole host of health problems (1-3) — but I was a sugar addict, and it was devastating to think that I would have to let go of this old friend and not have any sweetness in my life.

article thumbnail

Sleep tracking and the potential for digital endpoints

pharmaphorum

However, the health conditions that can arise from long-term insufficient sleep are far more serious: mental health disorders, immunodeficiency, diabetes, cardiovascular disease, obesity, hormone imbalances, and chronic pain or inflammation. Why is sleep being discussed more?

article thumbnail

Jab n Slim – Weight Loss in a Pen!

Fuld & Company Blog

The background of semaglutide Nearly 20 years ago the first glucagon-like peptide 1 (GLP-1), a class of Type 2 diabetes drug that improves blood sugar, was launched, creating what is today a market worth nearly $30B. This market was estimated to be worth over $80 billion, in addition to the $30 billion diabetes market.

article thumbnail

New Medication has Implications to avoid Would-be Chronic Diseases

PharmD Live

1 Obesity increases the risk for many health problems, such as type 2 diabetes, high blood pressure, heart disease, stroke, joint disorders, liver disease, gallstones, some types of cancer, and sleep apnea among other conditions. All patients with diabetes were excluded from the study. This number has increased dramatically from 30.5%